story of the week
Empagliflozin Lowers Risk of Death in Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular and Renal Outcomes With Empagliflozin in Heart Failure
N. Engl. J. Med 2020 Oct 08;383(15)1413-1424, M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, J Januzzi, S Verma, H Tsutsui, M Brueckmann, W Jamal, K Kimura, J Schnee, C Zeller, D Cotton, E Bocchi, M Böhm, DJ Choi, V Chopra, E Chuquiure, N Giannetti, S Janssens, J Zhang, JR Gonzalez Juanatey, S Kaul, HP Brunner-La Rocca, B Merkely, SJ Nicholls, S Perrone, I Pina, P Ponikowski, N Sattar, M Senni, MF Seronde, J Spinar, I Squire, S Taddei, C Wanner, F ZannadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.